Cargando…
Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
Lipid metabolic disorders have become a major global public health concern. Fatty liver and dyslipidemia are major manifestations of these disorders. Recently, MicroRNA-33 (miR-33), a post-transcriptional regulator of genes involved in cholesterol efflux and fatty acid oxidation, has been considered...
Autores principales: | Tao, Yaoye, Xu, Shengjun, Wang, Jianguo, Xu, Li, Zhang, Chenzhi, Chen, Kangchen, Lian, Zhengxing, Zhou, Junbin, Xie, Haiyang, Zheng, Shusen, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419650/ https://www.ncbi.nlm.nih.gov/pubmed/32848718 http://dx.doi.org/10.3389/fphar.2020.00921 |
Ejemplares similares
-
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020) -
The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis
por: Zhang, Chenzhi, et al.
Publicado: (2020) -
Integrative Metabolomics, Proteomics and Transcriptomics Analysis Reveals Liver Toxicity of Mesoporous Silica Nanoparticles
por: Li, Jing, et al.
Publicado: (2022) -
Antagomirs Targeting MiroRNA-134 Attenuates Epilepsy in Rats through Regulation of Oxidative Stress, Mitochondrial Functions and Autophagy
por: Sun, Jiahang, et al.
Publicado: (2017) -
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
por: Zhang, Chengcheng, et al.
Publicado: (2022)